WuXi PharmaTech (Cayman), Inc. (ADR) (NYSE:WX)
China-based pharmaceutical and biotechnology R&D outsourcing company which provides a integrated portfolio of laboratory and manufacturing services in the drug discovery and development process to pharmaceutical and biotechnology companies.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
EJDoran
(54.83)
Submitted: 3/28/2008 1:56:17 PM :
Start Price:
$22.30
WX Score:
-38.30
While the Chinese market is open, someone has to be the top dog in the Chinese pharma market and my bet is on these guys. Well run, low costs in a usually high cost sector, huge and growing market.
Recs
FLORIDAMONEYMAN
(< 20)
Submitted: 3/13/2008 10:14:26 PM :
Start Price:
$22.13
WX Score:
-37.76
FDA gave some good coments with this one, fast short run for a blast cash grab.
Recs
acbinvestor
(< 20)
Submitted: 1/10/2008 11:22:02 PM :
Start Price:
$28.54
WX Score:
-46.67
US economic recession is on the horizon.
Big pharmas have to cut costs and downsize. But R&D can not slow down. Thus, outsourcing is the trend. They can outsource to US based companies or overseas companies. WX has a huge cost advantage.
With the recent Apptec acquisition, it expands its service range and customer base. BTW, the IPO cash it harvested hasn't been touched since it maintains cash positive flow for years now. To make the money to work by buying Apptec is a smart move.
WX is the best drug research companies in China. With its huge talent pool and the enormous market potential in China, sky is the limit.
By setting up the first life science award in China, WX solidified its leadership status in China. The move enables WX to establish close ties to Chinese officials, academic researchers, potential talent pool and other industry insiders. With a small amount of money to hand out, it achieved the greatest PR result. Smart management team.
If you hear CVD's CEO saying that they have more outsource jobs than they can handle, you know WX will not be short of jobs.
Recs
modesto1
(48.49)
Submitted: 12/31/2007 7:01:19 PM :
Start Price:
$29.27
WX Score:
-44.10
Chinese CRO provides better service (more competent technicians) at a lower price for large pharmaceutical company clients than do US and EU based CROs. Expect WX to capture market share from firms like Covance, CRL, PPDI & PRXL in the coming 4 years as WX expands clinical trials services.
Recs
raisingAZ
(95.20)
Submitted: 12/14/2007 6:07:39 PM :
Start Price:
$28.50
WX Score:
-43.20
Another Chinese stock that is doing outstanding. It is only going to get more and more business internally and from us and Europe. They seem to be able to do excellent chemistry and do it on time and with excellent results.
Recs
ydliu
(37.19)
Submitted: 11/14/2007 1:18:34 PM :
Start Price:
$28.99
WX Score:
-42.54
A well-managed company looking to capture a growing share of the huge pharmaceutical outsourcing industry.
Recs
seijin0201
(< 20)
Submitted: 10/30/2007 1:05:53 AM :
Start Price:
$41.84
WX Score:
-55.32
One of 50 fastest growing companies in China. Great play in Pharma and Biotech....Dr. Ge Li, the company's Chairman and Chief Executive Officer received the Ernst & Young Entrepreneur Of The Year (EOY) China 2007 Award
Recs
cayamax
(< 20)
Submitted: 10/24/2007 10:42:59 PM :
Start Price:
$36.97
WX Score:
-51.80
I expect this stock to take off within the next four months.
Recs
godsend
(< 20)
Submitted: 10/20/2007 7:06:27 AM :
Start Price:
$32.51
WX Score:
-48.09
Supported by Chinese governement, hence good site for new complex.Top US formed PHD's and MBA's among staff. Buy on recent dip.
Recs
Recs
jpmrwb
(< 20)
Submitted: 10/9/2007 1:01:14 AM :
Start Price:
$35.54
WX Score:
-47.89
Well you know this had to happen. China needs pharma and this is a good play on that.
Recs
BLAYNE100
(51.91)
Submitted: 10/8/2007 5:15:44 PM :
Start Price:
$28.52
WX Score:
-39.01
Outsourcing technical drug work to companies such as WX will drive growth. Just like the gold rush in 1849, the tool providers made out like bandits, while only a few prospectors (drug companies) made a lot of money.
Recs
omagisi1
(< 20)
Submitted: 10/7/2007 4:49:06 PM :
Start Price:
$35.46
WX Score:
-47.92
China is in and so is WX. They call it the new Amgen.
Recs
arnie99
(< 20)
Submitted: 10/4/2007 9:57:48 AM :
Start Price:
$32.60
WX Score:
-45.26
Chinese CRO In drug discovery with momentum. Contracts w/ major pharma giants.
Recs
SteadySaber
(76.58)
Submitted: 10/2/2007 4:20:44 PM :
Start Price:
$33.00
WX Score:
-45.77
volume is about 4x on no news. china rallys.
Recs
tjqmaster
(< 20)
Submitted: 9/28/2007 6:15:56 PM :
Start Price:
$29.18
WX Score:
-40.69
Wuxi PharmaTech allows the OUTSOURCING of work that COULDN"T previously be outsourced. This is due to China's highly educated workforce. A highly educated workforce at a fraction of the cost is a no brainer for American and European Pharmaceutical companies.
Recs
IamStillLearning
(75.21)
Submitted: 9/20/2007 3:33:00 PM :
Start Price:
$30.50
WX Score:
-43.35
Strong BBB.
medical dental service, chinese outsourcing, maufacture.
strong sale, EPS growth.
high ROE.
Recs
motrolandjr
(< 20)
Submitted: 9/7/2007 7:32:28 PM :
Start Price:
$29.05
WX Score:
-44.68
WuXi PharmaTech, the largest pharmaceutical contract-research in CHINA
Recs
dank92
(38.52)
Submitted: 8/25/2007 11:43:09 PM :
Start Price:
$26.24
WX Score:
-38.45
Wuxi is a leading chinese pharma, the next china medical technologies.
Recs
imabugger
(< 20)
Submitted: 8/25/2007 10:57:51 AM :
Start Price:
$26.24
WX Score:
+38.45
who would actually buy drugs from china? corps, bodies, dead people, really sick people that are not getting better, people that like the taste of anti freeze.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 40 of 41 : « Previous 1 2 3 Next »